Core business

NCK’s core business is Synthetic Organic Chemistry

Cutting edge process

NCK provides cutting edge process development and API manufacturing (e.g. process development, analytical development, reference samples, supply of API for toxicology and human studies, API release, ICH stability studies as well as relevant progress reports and GMP documentation) for biotech and pharma companies who want to take NCEs from discovery to commercialization.

NCK offers all relevant services for fulfilling regulatory requirements when applying for an IND / IMPD. NCK is built on the foundation of synthetic organic chemistry, and we have seen and have been involved in most of the latest innovative chemistry.